Education
About Us
Working with TipRanks
Follow Us
Cann American (CNNA)
OTHER OTC:CNNA
CNNA Stock Chart & Stats
<$0.01
>-$0.01(-17.95%)
At close: 4:00 PM EST
<$0.01
>-$0.01(-17.95%)
Day’s Range― - ―
52-Week Range<$0.01 - $0.02
Previous CloseN/A
Volume55.22K
Average Volume (3M)N/A
Market Cap
$1.40M
Enterprise ValueN/A
Total Cash (Recent Filing)N/A
Total Debt (Recent Filing)$0.00
Price to Earnings (P/E)―
Beta0.61
Next EarningsN/A
EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)N/A
Shares Outstanding737,841,860
10 Day Avg. VolumeN/A
30 Day Avg. VolumeN/A
Financial Highlights & Ratios
PEG Ratio>-0.01
Price to Book (P/B)-0.26
Price to Sales (P/S)0.00
P/FCF Ratio148.33
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
CNNA FAQ
What was Cann American’s price range in the past 12 months?
Cann American lowest stock price was <$0.01 and its highest was $0.02 in the past 12 months.
What is Cann American’s market cap?
Cann American’s market cap is $1.40M.
When is Cann American’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
How were Cann American’s earnings last quarter?
Currently, no data Available
Is Cann American overvalued?
According to Wall Street analysts Cann American’s price is currently Overvalued.
Does Cann American pay dividends?
Cann American does not currently pay dividends.
What is Cann American’s EPS estimate?
Cann American’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Cann American have?
Cann American has 737,841,860 shares outstanding.
What happened to Cann American’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of Cann American?
Currently, no hedge funds are holding shares in CNNA
Company Description
Cann American
Cann American Corp., a development stage company, focuses on the development of Cannabis sativa strains for pets in various European Union countries. The company was formerly known as Canamed4Pets, Inc. and changed its name to Cann American Corp. in December 2019. Cann American Corp. was founded in 2004 and is based in Cloverdale, California.
MSP Recovery
―
Dermata Therapeutics
―
Bluejay Diagnostics
―
CERo Therapeutics Holdings
―
Psyence Biomedical
―